Managing symptoms in hypothyroid patients on adequate levothyroxine: a narrative review
The current standard of care for hypothyroidism is levothyroxin e (LT4) monotherapy to reduce levels of thyrotropin (thyroid-stimulating hormone, T SH) within its reference range and amelioration of any symptoms. A substantial minority continues to report hypothyroid-like symptoms despite optimized...
Main Authors: | Salman Razvi, Sanaa Mrabeti, Markus Luster |
---|---|
Format: | Article |
Language: | English |
Published: |
Bioscientifica
2020-12-01
|
Series: | Endocrine Connections |
Subjects: | |
Online Access: | https://ec.bioscientifica.com/view/journals/ec/9/11/EC-20-0205.xml |
Similar Items
-
Combination therapy of liothyronine and levothyroxine for hypothyroidism-induced dilated cardiomyopathy
by: Youngha Choi, et al.
Published: (2022-06-01) -
Optimal levothyroxine replacement adequately improves symptoms of hypothyroidism; Residual symptoms need further evaluation for other than hypothyroidism causation
by: Rekha Singh, et al.
Published: (2017-01-01) -
Levothyroxine-induced liver injury followed by complete recovery upon cessation of the drug: a case report
by: Abbas F. Hlaihel, et al.
Published: (2019-10-01) -
Hepcidin and CRP Levels in a Sample of Iraqi Hypothyroid Patients Treated with Levothyroxine
by: Haider D. Abdullah, et al.
Published: (2024-10-01) -
Update on therapeutic use of levothyroxine for the management of hypothyroidism during pregnancy
by: Bogumila Urgatz, et al.
Published: (2024-02-01)